Home / Street Sector / Vigorous Gainers/Losers Roundup: Talen Energy (NYSE:TLN), Colony Capital (NYSE:CLNY), Lion Biotechnologies (NASDAQ:LBIO)

Vigorous Gainers/Losers Roundup: Talen Energy (NYSE:TLN), Colony Capital (NYSE:CLNY), Lion Biotechnologies (NASDAQ:LBIO)

Shares of Talen Energy Corporation (NYSE:TLN) [Trend Analysis] swings enthusiastically in regular trading session, it a gain of 17.17% to close at $13.99. Talen Energy to be acquired by Riverstone for $14.00/share in cash in a transaction valued at $5.2 bln, agreement provides for a go-shop period (TLN). Talen Energy will be acquired for $14.00/share in cash. Affiliates of Riverstone currently own ~35% of the outstanding shares of Talen Energy common stock, which were issued in the June 2015 transaction that established Talen Energy by combining competitive generation assets that had been owned by affiliates of PPL Corp and affiliates of Riverstone.

The purchase price represents a 56% premium to the closing price of $9.00 per share on March 31, 2016, the last trading day before public reports of a potential sale of Talen Energy, and a 101 percent premium to the 60-day volume-weighted average price of $6.95/share through Mar 31. The transaction has a total enterprise value of ~$5.2 bln. Moving forward to saw long-term intention, the firm has various dividend or yield record, TLN has Dividend Yield of {dividend_yield} and experts calculate Return on Investment of -0.10%. The stock is going forward its fifty-two week low with 144.15% and lagging behind from its 52-week high price with -30.91%. TLN last month stock price volatility remained 4.69%.

Colony Capital, Inc. (NYSE:CLNY) [Trend Analysis] retains strong position in active trade, as shares scoring -5.50% to $17.35 in a active trade session, while looking at the shares volume, around 9.09 Million shares have changed hands in this session. The co, Colony Capital (CLNY) and NorthStar Realty Finance (NRF) announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger of equals transaction to create an internally-managed, diversified real estate and investment management platform.

The transaction has been unanimously approved by the Special Committees of NSAM and NRF, and the Board of Directors of Colony. The combined company will be named “Colony NorthStar, Inc.” Upon completion of the transaction, terms of which are detailed below, NSAM shareholders will own approximately 32.85%, Colony shareholders will own approximately 33.25% and NRF shareholders will own approximately 33.90% of the combined company on a fully diluted basis. The firm has institutional ownership of 97.20%, while insider ownership included 2.50%. CLNY attains analyst recommendation of 1.80 with week’s performance of -4.09%. Investors looking further ahead will note that the Price to next year’s EPS is 8.24%.

Lion Biotechnologies, Inc. (NASDAQ:LBIO) [Trend Analysis] knocking active thrust in leading trading session, shares a gain of 43.45% to 8.65 with around 10.48 Million shares have changed hands in this session. Lion Biotechnologies Inc. (LBIO) declared that it lifted $100M in a private placement of shares. Volume was 9.1 million shares in afternoon trade, compared with the full-day average of about 180,000 shares over the past 30 days, according to FactSet.

The company said early Friday it entered into agreements with institutional and other accredited investors to sell a total of 9.7 million common shares at $4.75 each, and 11.4 million Series B preferred non-voting shares, also at $4.75 each. The Series B shares will become convertible to one share of common stock. Separately, Lion said it named Maria Fardis as its Chief Executive, replacing Elma Hawkins, how had been CEO since January 2015. The stock is going forward its fifty-two week low with 104.01% and lagging behind from its 52-week high price with -27.92%.

Likewise the positive performance for the quarter recorded as 53.37% and for the year was -17.07%, while the YTD performance remained at 12.05%. LBIO has Average True Range for 14 days of 0.52.

 

About Aaron Smithies

Aaron Smithies has a wide look on current monetary and financial events. He is an editor and a writer. His views; At Streetwise Report, we think the best opportunities arise from a complete understanding of all investing disciplines in order to identify the most attractive stocks at any given time. Interests: Biotech, Finical markets, Dividend stock ideas & income, Energy stocks, Consumer goods stocks

Check Also

LifeLock, Inc. (NYSE:LOCK)- Most Active Trio on Investment Estimation: Fidelity National Information Services (NYSE:FIS)

LifeLock, Inc. (NYSE:LOCK) persists its position slightly strong in context of buying side, while shares …

Leave a Reply

Your email address will not be published. Required fields are marked *